Eli Lilly, other Big Pharma firms are making it harder for low-income patients to get discount drug

[mucifer]

Source: Chicago Tribune

But the 340B program is in danger after Indianapolis-based pharmaceutical giant Eli Lilly announced in 2020 that it would not provide drugs to clinics unless they administer them on-site or through a single contract pharmacy — a hurdle that makes it more difficult for patients to receive the discounted Eli Lilly drugs, according to doctors, pharmacists and clinic administrators.

Other manufacturers, including AstraZeneca, Novartis, Sanofi-Aventis, Novo Nordisk and United Therapeutics, have since followed, according to a recent federal lawsuit, and doctors now worry about a further cascading effect.

Illinois Attorney General Kwame Raoul in December blasted the move by Eli Lilly and other companies. With more than two dozen other attorneys general, he signed a letter to Health and Human Services Secretary Alex Azar urging action.

“Access to affordable medications is critical, and I urge the Department of Health and Human Services to use the power afforded to the department to enforce and regulate the (program),” Raoul said in a statement.



Read more: https://www.chicagotribune.com/news/breaking/ct-federal-drug-pricing-program-risk-chicago-clinics-20210104-q6ktncof6ncqpmmezxaqq4ciyq-story.html

---

pharmaceutical companies evil knows no bounds.

[PatSeg]

1. Oh gee

I guess they must not be making enough money.